Vivo Capital, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,692,234
-24.6%
137,4110.0%0.40%
+19.8%
Q2 2023$4,900,076
+40.4%
137,4110.0%0.34%
+39.7%
Q1 2023$3,490,239
+62527.7%
137,4110.0%0.24%
-62.3%
Q4 2022$5,573
-99.9%
137,4110.0%0.64%
+28.1%
Q3 2022$4,541,000
-6.1%
137,4110.0%0.50%
+3.1%
Q2 2022$4,838,000
-23.4%
137,4110.0%0.49%
+11.7%
Q1 2022$6,320,000
-30.6%
137,4110.0%0.44%
-20.8%
Q4 2021$9,110,000
+6.2%
137,4110.0%0.55%
+42.6%
Q3 2021$8,579,000
-24.6%
137,4110.0%0.38%
-21.9%
Q2 2021$11,380,000
+24.9%
137,4110.0%0.49%
+54.1%
Q1 2021$9,112,000
-42.1%
137,411
-33.0%
0.32%
-54.4%
Q4 2020$15,737,000
-36.6%
205,091
-64.4%
0.70%
-51.1%
Q3 2020$24,824,000
-0.3%
576,5050.0%1.44%
-19.6%
Q2 2020$24,899,000
+12.6%
576,505
-25.0%
1.78%
-10.9%
Q1 2020$22,115,000
-69.8%
768,674
-72.2%
2.00%
-70.8%
Q2 2019$73,277,000
+71.5%
2,765,153
+18.8%
6.87%
+61.2%
Q1 2019$42,728,000
+47.7%
2,328,4750.0%4.26%
+15.4%
Q4 2018$28,920,000
-35.2%
2,328,4750.0%3.69%
-17.9%
Q3 2018$44,637,000
+72.7%
2,328,475
+22.6%
4.50%
+35.1%
Q2 2018$25,840,000
+88.6%
1,900,0000.0%3.33%
+71.6%
Q1 2018$13,699,0001,900,0001.94%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders